
New legislation to reduce fuel prices in Poland took effect on Tuesday, as the government in Warsaw tries to reduce the impact on consumers of increased global oil prices due to the Iran conflict.
According to the Energy Ministry, a litre of regular petrol may not cost more than 6.16 zloty (about $1.65). The maximum retail price for a litre of super is now 6.76 zloty and for diesel 7.60 zloty.
The legislation, signed into law on Friday, provides for a reduction in VAT on fuels from the current 23% to 8%. In addition, the energy minister will be able to reduce the level of the energy tax on fuel until the end of June.
The government had already announced a reduction to the minimum permitted under EU law for petrol and diesel, which comes to just under €0.07 ($0.08) per litre.
A maximum retail price for fuel is to apply until the end of June. That price will be set daily by the energy minister on the basis of average wholesale prices and the operating costs of the largest suppliers. Violations can be punished with fines of up to the equivalent of €230,000.
latest_posts
- 1
Nine in 10 German industrial firms expect Iran war to hit business - 2
Why won't NASA's Artemis 2 astronauts land on the moon when they get there? - 3
Deadly Switzerland ski resort fire was likely started by sparklers attached to champagne bottles, officials say - 4
After harsh winter, Ukrainians find joy in releasing bats rescued from war - 5
NASA, in a rare move, cuts space station mission short after an astronaut's medical issue
Is Iran using cryptocurrencies to circumvent sanctions?
Most loved Seared Chicken: Which Chain Rules?
Avoid Slam: Clearing the Street for the Eventual fate of Standard Size Trucks
Medtronic has 'significant firepower' for multiple acquisitions, executives say
UK forecast to face weaker growth and higher inflation from Iran war
4 Family SUVs: Joining Solace and Style
New law puts familiar drinks, creams and gummies in legal limbo
With Obamacare premium hikes, more people opting for no coverage or cheaper plans
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet













